Technical Analysis for JAGX - Jaguar Animal Health, Inc.
|Grade||Last Price||% Change||Price Change|
JAGX closed up 3.85 percent on Friday, January 18, 2019, on 3.95 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
|Weak or Absent||Down||Down||Down|
|See historical JAGX trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Shooting Star Candlestick||Bearish||0.00%|
|Jan 18||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jan 18||Crossed Above 20 DMA||Bullish||0.00%|
|Jan 18||Pocket Pivot||Bullish Swing Setup||0.00%|
|Jan 18||Volume Surge||Other||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 17||Fell Below 20 DMA||Bearish||3.85%|
|Jan 17||180 Bearish Setup||Bearish Swing Setup||3.85%|
|Jan 17||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||3.85%|
|Jan 17||Narrow Range Bar||Range Contraction||3.85%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more JAGX news...
|52 Week High||6.6|
|52 Week Low||0.115|
|200-Day Moving Average||1.1323|
|50-Day Moving Average||0.3485|
|20-Day Moving Average||0.2637|
|10-Day Moving Average||0.2929|
|Average True Range||0.0434|
|Chandelier Exit (Long, 3 ATRs )||0.2598|
|Chandelier Exit (Short, 3 ATRs )||0.2452|
|Upper Bollinger Band||0.3609|
|Lower Bollinger Band||0.1665|
|Percent B (%b)||0.53|
|MACD Signal Line||-0.0221|
|Market Cap||29.21 Million|
|Num Shares||108 Million|
|Price-to-Earnings (P/E) Ratio||-1.73|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||0.35|
|Resistance 3 (R3)||0.35||0.33||0.33|
|Resistance 2 (R2)||0.33||0.31||0.33||0.33|
|Resistance 1 (R1)||0.30||0.30||0.32||0.30||0.32|
|Support 1 (S1)||0.25||0.26||0.27||0.25||0.22|
|Support 2 (S2)||0.23||0.25||0.23||0.21|
|Support 3 (S3)||0.20||0.23||0.21|
|Support 4 (S4)||0.20|